EP3661494
USE OF TASIMELTEON FOR THE TREATMENT OF AFFECTIVE DISORDERS IN MAJORITY BLACK AFRICAN PATIENTS
Staða:
EP einkaleyfi: Þýðing ekki lögð innEP ums.dags:
2.8.2018EP veitt dags:
11.10.2023EP umsóknarnúmer:
18755664.2
Upplýsingar hjá EPO:
European Patent Register
Hámarksgildistími:
1.8.2038
Titill á ensku:
USE OF TASIMELTEON FOR THE TREATMENT OF AFFECTIVE DISORDERS IN MAJORITY BLACK AFRICAN PATIENTSTungumál veitts einkaleyfis:
Enska
Tímalína
Í dag
2.8.2018EP umsókn
11.10.2023EP veiting
Eigandi
Nafn:
Vanda Pharmaceuticals Inc.Heimilisfang:
2200 Pennsylvania Ave NW Suite 300-E, Washington, DC 20037, US
Nafn:
Polymeropoulos, MihaelHeimilisfang:
10627 River's Bend Lane, Potomac, MD 20854, US
Nafn:
Polymeropoulos, ChristosHeimilisfang:
10627 River's Bend Lane, Potomac, MD 20854, US
Nafn:
Xiao, ChangfuHeimilisfang:
1235 Providence Terrace, McLean, VA 22101, US
Uppfinningamaður
Nafn:
POLYMEROPOULOS, MihaelHeimilisfang:
Vienna VA 22182, US
Nafn:
POLYMEROPOULOS, ChristosHeimilisfang:
Vienna VA 22182, US
Nafn:
XIAO, ChangfuHeimilisfang:
McLean, VA 22101, US
Forgangsréttur
Númer:
201762540200 PDagsetning:
2.8.2017Land:
US
Flokkun
Flokkar:
A61K 31/343, A61K 45/06, A61P 25/24